217 related articles for article (PubMed ID: 1698306)
1. Antigen-presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions.
Baadsgaard O; Lisby S; Avnstorp C; Clemmensen O; Lange-Vejlsgaard G
Scand J Immunol; 1990 Sep; 32(3):217-24. PubMed ID: 1698306
[TBL] [Abstract][Full Text] [Related]
2. Phenotype, ultrastructure, and function of CD1+DR+ epidermal cells that express CD36 (OKM5) in cutaneous T-cell lymphoma.
Lisby S; Baadsgaard O; Cooper KD; Hansen ER; Mehregan D; Thomsen K; Allen E; Lange Vejlsgaard G
Scand J Immunol; 1990 Aug; 32(2):111-9. PubMed ID: 1697095
[TBL] [Abstract][Full Text] [Related]
3. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
Hansen ER; Baadsgaard O; Lisby S; Cooper KD; Thomsen K; Vejlsgaard GL
J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933
[TBL] [Abstract][Full Text] [Related]
5. Decreased number and function of antigen-presenting cells in the skin following application of irritant agents: relevance for skin cancer?
Lisby S; Baadsgaard O; Cooper KD; Vejlsgaard GL
J Invest Dermatol; 1989 Jun; 92(6):842-7. PubMed ID: 2786039
[TBL] [Abstract][Full Text] [Related]
6. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
[TBL] [Abstract][Full Text] [Related]
7. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin.
Baadsgaard O; Lisby S; Wantzin GL; Wulf HC; Cooper KD
J Immunol; 1989 Jun; 142(12):4213-8. PubMed ID: 2470820
[TBL] [Abstract][Full Text] [Related]
8. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
Ashworth J; Kahan MC; Breathnach SM
Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
[TBL] [Abstract][Full Text] [Related]
9. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
Prens EP; Benne K; van Joost T; Benner R
J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
[TBL] [Abstract][Full Text] [Related]
10. The role of human epidermal Langerhans cells in skin immunity.
Braathen LR
Derm Beruf Umwelt; 1987; 35(2):58-61. PubMed ID: 2439270
[TBL] [Abstract][Full Text] [Related]
11. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion.
Cooper KD; Oberhelman L; Hamilton TA; Baadsgaard O; Terhune M; LeVee G; Anderson T; Koren H
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8497-501. PubMed ID: 1382291
[TBL] [Abstract][Full Text] [Related]
12. In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted.
Meunier L; Bata-Csorgo Z; Cooper KD
J Invest Dermatol; 1995 Dec; 105(6):782-8. PubMed ID: 7490472
[TBL] [Abstract][Full Text] [Related]
13. The role of Langerhans cells and keratinocytes in epidermal immunity.
Choi KL; Sauder DN
J Leukoc Biol; 1986 Mar; 39(3):343-58. PubMed ID: 2418143
[TBL] [Abstract][Full Text] [Related]
14. Mixed epidermal cell lymphocyte reaction: HLA-DR+ cells exhibit a greater immunostimulatory activity than CD1a+ cells.
Dobmeyer TS; Dobmeyer JM; Klein SA; Schopf RE; Helm EB; Rossol R
Adv Exp Med Biol; 1995; 378():393-6. PubMed ID: 8526102
[No Abstract] [Full Text] [Related]
15. [The Langerhans cell: outpost of the immune system in the epidermis].
Bieber T
Hautarzt; 1986 Aug; 37(8):424-31. PubMed ID: 3489696
[TBL] [Abstract][Full Text] [Related]
16. Increases in human epidermal DR+CD1+, DR+CD1-CD36+, and DR-CD3+ cells in allergic versus irritant patch test responses.
Gerberick GF; Rheins LA; Ryan CA; Ridder GM; Haren M; Miller C; Oelrich DM; von Bargen E
J Invest Dermatol; 1994 Oct; 103(4):524-9. PubMed ID: 7523531
[TBL] [Abstract][Full Text] [Related]
17. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
[TBL] [Abstract][Full Text] [Related]
18. Ratio of Langerhans cells to Thy-1+ dendritic epidermal cells in murine epidermis influences the intensity of contact hypersensitivity.
Bigby M; Kwan T; Sy MS
J Invest Dermatol; 1987 Nov; 89(5):495-9. PubMed ID: 2889783
[TBL] [Abstract][Full Text] [Related]
19. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
Cooper KD; Neises GR; Katz SI
J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
[TBL] [Abstract][Full Text] [Related]
20. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
